1. Home
  2. Medical Research
  3. Sleepy Hollow, NY
  4. International Thymic Malignancy Interest Group

International Thymic Malignancy Interest Group

International Thymic Malignancy Interest Group is ranked among medical research organizations in Sleepy Hollow, NY, with an America's Best Score of 61 out of 100, based on its 2025 Form 990.

  • Sleepy Hollow, NY
  • Tax-exempt since 2010
  • EIN: 27-1652696
itmig.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
61OF 100 Ranked in Sleepy Hollow Medical Research How this score is calculated

Organization summary

International Thymic Malignancy Interest Group is a 501(c)(3) organization, classified under Medical Research (NTEE H19). Contributions are tax-deductible.

102 Legend Drive, Sleepy Hollow, NY 10591-3400

In fiscal year 2025 it reported $216,569 in revenue and $313,492 in expenses, with contributions making up 100.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the disciplines. The academic journal Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies, has reopened More than 2000 patients are enrolled.

Largest programs · fiscal year 2025

  • ITMIG is aligned with the Foundation for Thymic Cancer Research to advance program services through coordination of the executive director. The executive director is responsible for all activities related to the organization and all program services. $183,000 spent · 71.9% of program spending
  • Research and related expenses. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open to all researches and has data transfer agreements with all major institutions. $75,000 spent · 29.5% of program spending
  • The 2024 Annual Meeting was held in Yokohama, Japan, in collaboration with the Japan Lung Cancer Society. The abstract book from the meeting is available in MEDIASTINUM. $55,672 spent · 21.9% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 81¢ went to programs, 19¢ to management and 0¢ to fundraising.

  • Programs $254,492
  • Management $59,000
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score61 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves8.2 mo; 8.2 mo in cash5.7 / 25
Financial balance (median margin)+16.8%8.5 / 20
Transparency2 full 990s, latest TY202515 / 20
Program growth+36.6% / yr15 / 15
Track record16 years6.4 / 10
Debt load0.0% of assets10 / 10
Total60.7 → 61
Spending on programs
Not scored; America's Best needs 65%+
81%Meets

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$216,569Fiscal year 20252022: $106,83220222023: $164,48620232024: $377,80620242025: $216,5692025
Expenses$313,492Fiscal year 20252022: $95,36920222023: $142,90320232024: $229,58020242025: $313,4922025
Total assets$215,219Fiscal year 20252022: $146,34020222024: $316,14920242025: $215,2192025
Total liabilities$0Fiscal year 20252022: $020222024: $020242025: $02025
Fiscal year ending December 2025
Revenue$216,569
Expenses$313,492
Net income−$96,923
Net assets$215,219

Notable sources of revenue

Percent of total revenue
Contributions$216,569
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$215,219
Total liabilities$0
Net assets$215,219

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$377,806
Expenses$229,580
Net income$148,226
Net assets$316,149

Notable sources of revenue

Percent of total revenue
Contributions$377,806
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$316,149
Total liabilities$0
Net assets$316,149

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$164,486
Expenses$142,903
Net income$21,583
Net assets$167,923

Notable sources of revenue

Percent of total revenue
Contributions$164,486
Program services—
Investment income—
Other (net)$0

Assets / debt

Total assets—
Total liabilities—
Net assets$167,923

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$106,832
Expenses$95,369
Net income$11,463
Net assets$146,340

Notable sources of revenue

Percent of total revenue
Contributions$106,832
Program services$0
Investment income$0
Other (net)$0

Assets / debt

Total assets$146,340
Total liabilities$0
Net assets$146,340

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?